// App-Quantinova.ai

1388 : Utility of humanized animal models for in vivo evaluation of NK TICA™ novel Bicycle® tumor targeted immune cell agonists® Bicycle TICA™ designed to engage NK cells

Researchers

Presenter

  • Lukas Stanczuk

Principal Investigators

  • Johanna Lahdenranta

  • Fay Dufort

  • Christopher Leitheiser

  • Punit Upadhyaya

  • Kevin McDonnell

  • Philip Brandish

  • Nicholas Keen

Medical Centers

  • ADC Therapeutics, London, UK

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Aldo-keto Reductase Family 1 Member B10

  • Natural Killer cells

  • Cluster of Differentiation 34

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved